- Comparing Whey and Plant-Based Protein: Which is Best?
- How Long Does Nicotine Remain in Your System?
- The Best Time of Day to Drink Bone Broth to Maximize Health Benefits
- 8 Ways to Increase Dopamine Naturally
- 7 Best Breads for Maintaining Stable Blood Sugar
- Gelatin vs. Collagen: Which is Best for Skin, Nails, and Joints?
- The Long-Term Effects of Daily Turmeric Supplements on Liver Health
- Could Your Grocery Store Meat Be Causing Recurring UTIs?
- Are You Making This Expensive Thermostat Error This Winter?
- Recognizing the Signs of Hypothyroidism
Internal Tissue Adhesive Approved

The U.S. Food and Drug Administration has approved the first tissue adhesive for internal use.
Known as TissuGlu, surgeons can use the urethane-based adhesive to connect tissue flaps created during surgery to remove extra fat or skin, or to restore weak or separated abdominal muscles (abdominoplasty). The new adhesive may reduce or eliminate the need for surgical drains to remove fluid between such flaps, the agency said in a news release.
“The FDA’s approval of the first synthetic adhesive for internal use will help some abdominoplasty patients get back to their daily routine after surgery more quickly than if surgical drains had been inserted,” Dr. William Maisel, deputy director for science at FDA’s Center for Devices and Radiological Health, said in the news release.
The product was evaluated in a clinical trial of 130 people who had elective abdominoplasty, half of whom received TissuGlu with no surgical drains and half of whom received surgical drains. Among the TissuGlu group, 73 percent did not need any postoperative interventions to drain fluid, the FDA said.
TissuGlu is produced by Cohera Medical, based in Pittsburgh.
More information
Visit the FDA to learn more.
Source: HealthDay
Copyright © 2026 HealthDay. All rights reserved.










